Anish Pharma Research Centre Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 15-06-2024
- Paid Up Capital ₹ 0.30 M
as on 15-06-2024
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 15-06-2024
- Revenue 90.06%
(FY 2023)
- Profit 3.89%
(FY 2023)
- Ebitda -20.23%
(FY 2023)
- Net Worth 22.09%
(FY 2023)
- Total Assets 18.18%
(FY 2023)
About Anish Pharma Research Centre
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.50 Cr.
Yogendra Samant and Ravindra Samant serve as directors at the Company.
- CIN/LLPIN
U24234MH1999PTC119975
- Company No.
119975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Anish Pharma Research Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Samant  | Director | 21-May-1999 | Current |
| Yogendra Samant | Director | 15-Apr-2004 | Current |
Financial Performance and Corporate Structure Insights of Anish Pharma Research Centre.
Anish Pharma Research Centre Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 90.06% increase. The company also saw a slight improvement in profitability, with a 3.89% increase in profit. The company's net worth Soared by an impressive increase of 22.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anish Pharma Research Centre?
In 2023, Anish Pharma Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anish Pharmaequip Private LimitedActive 34 years 4 monthsYogendra Samant and Ravindra Samant are mutual person
Muso Kozo Properties LlpActive 6 years 5 monthsYogendra Samant and Ravindra Samant are mutual person
- Ashay Machines Private LimitedActive 29 years 1 month
Yogendra Samant and Ravindra Samant are mutual person
- Aakar Machines Private LimitedActive 21 years 10 months
Yogendra Samant and Ravindra Samant are mutual person
- Roots Formulations Private LimitedActive 4 years 10 months
Yogendra Samant and Ravindra Samant are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Dec 2020 | ₹1.50 Cr | Open |
How Many Employees Work at Anish Pharma Research Centre?
Unlock and access historical data on people associated with Anish Pharma Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anish Pharma Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anish Pharma Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
